AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24802242 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/r) alone
Number of subjects: 34
Study 24802242 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 NRTI plus protease inhibitor)
Number of subjects: 34
Study 22285578 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT with lateral LV lead position
Number of subjects: 346
Study 22285578 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT with non-apical LV lead position
Number of subjects: 346
Study 22285578 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT with lateral LV position
Number of subjects: 346
Study 22285578 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT with non-apical LV position
Number of subjects: 346
Study 22285578 — intervention group
Group type: COMPARATOR
Intervention: RV apical lead position
Number of subjects: 346
Study 20348362 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Relational Assessment Procedure (IRAP)
Number of subjects: 0
Study 20348362 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 0
Study 20348362 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit attitudes towards overweight individuals
Number of subjects: 0
Study 20348362 — intervention group
Group type: EXPERIMENTAL
Intervention: IRAP
Number of subjects: 0
Study 20348362 — intervention group
Group type: COMPARATOR
Intervention: Explicit measure
Number of subjects: 0
Study 18595176 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided peer support group (GPSG)
Number of subjects: 106
Study 18595176 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 106
Study 15772960 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized studies
Number of subjects: 17
Study 12523214 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved hand hygiene
Number of subjects: 0
Study 12523214 — intervention group
Group type: EXPERIMENTAL
Intervention: Available space per child
Number of subjects: 0
Study 12523214 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise and indoor climate
Number of subjects: 0
Study 12523214 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent outdoors
Number of subjects: 0
Study 10632035 — intervention group
Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 0
Study 10632035 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord-injured patients
Number of subjects: 0
Study 7488477 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block with bupivacaine
Number of subjects: 45
Study 7488477 — intervention group
Group type: COMPARATOR
Intervention: Interpleural block with bupivacaine
Number of subjects: 45
Study 1592850 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretransfusion radiofrequency heating of stored blood
Number of subjects: 0
Study 1592850 — intervention group
Group type: COMPARATOR
Intervention: Unwarmed blood pack
Number of subjects: 0
Study 6092990 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (45‐60 mg/M2)
Number of subjects: 14
Study 6092990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31498137 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT) - less affected limb blocked by a splint
Number of subjects: 10
Study 31498137 — intervention group
Group type: COMPARATOR
Intervention: Control group - undergoing bi-manual treatment
Number of subjects: 10
Study 30045424 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% energy trans fatty acid supplementation
Number of subjects: 53
Study 30045424 — intervention group
Group type: COMPARATOR
Intervention: <0.01% energy trans fatty acids (control)
Number of subjects: 53
Study 24228803 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (500mg daily)
Number of subjects: 36
Study 24228803 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA plus EPA mixture (500mg daily)
Number of subjects: 36
Study 24228803 — intervention group
Group type: COMPARATOR
Intervention: Wheat germ oil (control)
Number of subjects: 36
Study 21950727 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 224
Study 21950727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 19174534 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 18
Study 19174534 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 17197000 — intervention group
Group type: EXPERIMENTAL
Intervention: Aware of bedtime
Number of subjects: 14
Study 17197000 — intervention group
Group type: COMPARATOR
Intervention: No knowledge of bedtime
Number of subjects: 14
Study 17197000 — intervention group
Group type: COMPARATOR
Intervention: Misinformed about bedtime
Number of subjects: 14
Study 16080791 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum ME‐3 in fermented goat milk (daily dose 11.8 log CFU)
Number of subjects: 45
Study 16080791 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum ME‐3 in capsules (daily dose 9.2 CFU)
Number of subjects: 45
Study 16080791 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 45
Study 16080791 — intervention group
Group type: COMPARATOR
Intervention: Goat milk (control for fermented milk)
Number of subjects: 45
Study 12154153 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment (up to 40 mg/day)
Number of subjects: 0
Study 12154153 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (up to 1,200 mg/day)
Number of subjects: 0
Study 9479069 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic word classes (6 classes based on factor analysis of word ratings)
Number of subjects: 52
Study 9479069 — intervention group
Group type: COMPARATOR
Intervention: Checkerboard reversal stimulus (control condition)
Number of subjects: 52
Study 7995059 — intervention group
Group type: EXPERIMENTAL
Intervention: Single pulse therapy (500 mg of methylprednisolone)
Number of subjects: 90
Study 7995059 — intervention group
Group type: EXPERIMENTAL
Intervention: Second pulse therapy at 24 hours (500 mg of methylprednisolone)
Number of subjects: 90
Study 7995059 — intervention group
Group type: EXPERIMENTAL
Intervention: Second pulse therapy at 48 hours (500 mg of methylprednisolone)
Number of subjects: 90
Study 7995059 — intervention group
Group type: COMPARATOR
Intervention: Second pulse therapy (at 24h and 48h)
Number of subjects: 90
Study 2838681 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMW heparin)
Number of subjects: 70
Study 2838681 — intervention group
Group type: COMPARATOR
Intervention: Standard unfractionated heparin (UF heparin)
Number of subjects: 70
Study 30982972 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver
Number of subjects: 108
Study 29606103 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined educational and environmental intervention in the workplace
Number of subjects: 145
Study 29606103 — intervention group
Group type: COMPARATOR
Intervention: Control group (one organization)
Number of subjects: 145
Study 28643094 — intervention group
Group type: EXPERIMENTAL
Intervention: Double reading of tomosynthesis + S‐2D (F)
Number of subjects: 163
Study 28643094 — intervention group
Group type: COMPARATOR
Intervention: Single reading of S‐2D alone (A)
Number of subjects: 163
Study 28643094 — intervention group
Group type: COMPARATOR
Intervention: Single reading of tomosynthesis alone (B)
Number of subjects: 163
Study 28643094 — intervention group
Group type: COMPARATOR
Intervention: Single reading of joint interpretation of tomosynthesis + S‐2D (C)
Number of subjects: 163
Study 28643094 — intervention group
Group type: COMPARATOR
Intervention: Double reading of S‐2D alone (D)
Number of subjects: 163
Study 28643094 — intervention group
Group type: COMPARATOR
Intervention: Double reading of tomosynthesis alone (E)
Number of subjects: 163
Study 25837379 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 267
Study 23912139 — intervention group
Group type: EXPERIMENTAL
Intervention: Start For Life intervention (30 minutes/day for 9 months)
Number of subjects: 0
Study 21429793 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive programme in addition to usual care
Number of subjects: 522
Study 21429793 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 522
Study 19129044 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed estimation method using the expectation maximization (EM) algorithm with the bootstrap method
Number of subjects: 0
Study 19129044 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed testing procedure
Number of subjects: 0
Study 16337497 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (2 mug/kg/min, intravenously for 6 hours)
Number of subjects: 192
Study 16337497 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 192
Study 14605030 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrupt discontinuation of nitrate treatment (study group)
Number of subjects: 120
Study 14605030 — intervention group
Group type: COMPARATOR
Intervention: Continuation of nitrate treatment (control group)
Number of subjects: 120
Study 11117089 — intervention group
Group type: EXPERIMENTAL
Intervention: Notch depth index (NDI) with a cutoff value of 0.14
Number of subjects: 288
Study 11117089 — intervention group
Group type: COMPARATOR
Intervention: Uterine artery resistance index (RI)
Number of subjects: 288
Study 11117089 — intervention group
Group type: COMPARATOR
Intervention: Peak systolic to early diastolic velocity (A/C) ratio
Number of subjects: 288
Study 11117089 — intervention group
Group type: EXPERIMENTAL
Intervention: NDI with a cutoff value of 0.14
Number of subjects: 288
Study 8975965 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 MU IFN daily
Number of subjects: 30
Study 8975965 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 MU IFN plus regular phlebotomies
Number of subjects: 30
Study 8975965 — intervention group
Group type: COMPARATOR
Intervention: 3 MU IFN administered 3 x week for 6 months (control)
Number of subjects: 30
Study 1401602 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 613
Study 1401602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study 3890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesulergine 10 mg daily
Number of subjects: 20
Study 3890700 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesulergine 20 mg daily
Number of subjects: 20
Study 3890700 — intervention group
Group type: COMPARATOR
Intervention: Levodopa-carbidopa (LD-CD)
Number of subjects: 20
Study 31389383 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib + ara-c
Number of subjects: 30
Study 31389383 — intervention group
Group type: COMPARATOR
Intervention: Imatinib alone
Number of subjects: 30
Study 30007996 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor integration training combined with conventional physiotherapy, 2 times per week for 6 weeks
Number of subjects: 24
Study 30007996 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 24
Study 27003201 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Distance (6MWD)
Number of subjects: 187
Study 24189151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 0
Study 24189151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24189151 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants of mothers on ART
Number of subjects: 0
Study 24189151 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants of mothers with CD4 counts ≥ 350 cells/mm³ not on ART
Number of subjects: 0
Study 24189151 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP and Placebo
Number of subjects: 0
Study 22507901 — intervention group
Group type: EXPERIMENTAL
Intervention: HACE
Number of subjects: 26
Study 22507901 — intervention group
Group type: EXPERIMENTAL
Intervention: HAE
Number of subjects: 26
Study 22507901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HACE and HAE
Number of subjects: 26
Study 20454927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixabepilone plus capecitabine (40 mg/m² intravenously on day 1 of a 21-day cycle plus 2,000 mg/m² orally on days 1-14 of a 21-day cycle)
Number of subjects: 752
Study 20454927 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine alone (2,500 mg/m² on the same schedule)
Number of subjects: 752
Study 20454927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixabepilone plus capecitabine in KPS 70-80 subgroup
Number of subjects: 752
Study 17989373 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (median dosage per week: 1300 mg)
Number of subjects: 76
Study 17989373 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (median dosage per week: 525 mg)
Number of subjects: 76
Study 15900423 — intervention group
Group type: EXPERIMENTAL
Intervention: External-beam irradiation administered as a 60-Gy dose under conditions of acute hypoxia
Number of subjects: 307
Study 15900423 — intervention group
Group type: COMPARATOR
Intervention: External-beam irradiation administered as a 40-Gy dose under normal oxygenation conditions
Number of subjects: 307
Study 15900423 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-field irradiation up to T12 in hypoxic condition
Number of subjects: 307
Study 15900423 — intervention group
Group type: COMPARATOR
Intervention: Extended-field irradiation up to L4 in hypoxic condition
Number of subjects: 307
Study 15900423 — intervention group
Group type: COMPARATOR
Intervention: Lower dose under normoxic conditions
Number of subjects: 307
Study 15900423 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxyradiotherapy
Number of subjects: 307
Study 12107951 — intervention group
Group type: EXPERIMENTAL
Intervention: Two health screenings
Number of subjects: 2000
Study 12107951 — intervention group
Group type: EXPERIMENTAL
Intervention: Two health screenings and a 45-minute follow-up consultation annually with their general practitioner
Number of subjects: 2000
Study 12107951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health screenings)
Number of subjects: 2000
Study 10063243 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Drawing: Hospital
Number of subjects: 0
Study 7590643 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms 3-keto-desogestrel (KDG) with 30 micrograms ethinylestradiol (EE)
Number of subjects: 0
Study 7590643 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel (DG) with 30 micrograms ethinylestradiol (EE)
Number of subjects: 0
Study 2249126 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin 20 micrograms
Number of subjects: 22
Study 2249126 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin 40 micrograms
Number of subjects: 22
Study 2249126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 537624 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypia in colorectal adenomatous polyps
Number of subjects: 3
Study 31467066 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting G-CSF for all chemotherapy cycles
Number of subjects: 84
Study 31467066 — intervention group
Group type: COMPARATOR
Intervention: Short-acting G-CSF for first cycle and treatment per physician discretion for subsequent cycles
Number of subjects: 84
Study 27932353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg/d) + Statin (E+S)
Number of subjects: 260
Study 27932353 — intervention group
Group type: COMPARATOR
Intervention: Statin Monotherapy (S)
Number of subjects: 260
Study 26692013 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating 25-hydroxyvitamin D concentration
Number of subjects: 5545
Study 23606983 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg at bed time)
Number of subjects: 203
Study 23606983 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (100 ug twice daily)
Number of subjects: 203
Study 23606983 — intervention group
Group type: EXPERIMENTAL
Intervention: Both montelukast and fluticasone
Number of subjects: 203
Study 21385145 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily after THR
Number of subjects: 0
Study 21385145 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban after TKR
Number of subjects: 0
Study 21385145 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran 220 mg once daily
Number of subjects: 0
Study 21385145 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran
Number of subjects: 0
Study 19923527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg IV before incision, 24-h infusion at 2 microg x kg(‐1) x min(‐1))
Number of subjects: 154
Study 19923527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (blinded saline bolus and infusion)
Number of subjects: 154
Study 17352522 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0
Study 17352522 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel added to aspirin therapy
Number of subjects: 0
Study 15539040 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (at least 45 min, 5 days/week for 12 months)
Number of subjects: 173
Study 15539040 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 173
Study 11418225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg per day
Number of subjects: 68
Study 11418225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 9251877 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homoeopathic prophylaxis
Number of subjects: 63
Study 9251877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 8389421 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble fiber diet
Number of subjects: 43
Study 8389421 — intervention group
Group type: COMPARATOR
Intervention: Insoluble fiber diet
Number of subjects: 43
Study 3120604 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 16
Study 3120604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31904418 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-RPA assay
Number of subjects: 238
Study 31904418 — intervention group
Group type: COMPARATOR
Intervention: Simplex RT-PCR
Number of subjects: 238
Study 31904418 — intervention group
Group type: COMPARATOR
Intervention: Multiplex RT-PCR
Number of subjects: 238
Study 31904418 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-RPA, Simplex RT-PCR, Multiplex RT-PCR, ELISA
Number of subjects: 238
Study 29865941 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis with plantar flexion stop
Number of subjects: 42
Study 29865941 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis with plantar flexion resistance
Number of subjects: 42
Study 29865941 — intervention group
Group type: COMPARATOR
Intervention: Shod gait without an ankle-foot orthosis
Number of subjects: 42
Study 26968750 — intervention group
Group type: EXPERIMENTAL
Intervention: Translated letter
Number of subjects: 60
Study 24887239 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal saline irrigation (NSI)
Number of subjects: 860
Study 22687704 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A - Posted questionnaires with both electronic and paper response options for both the initial and reminder postal requests
Number of subjects: 752
Study 22687704 — intervention group
Group type: COMPARATOR
Intervention: Group B - Posted questionnaires with an electronic response option for the initial request, and both electronic and paper response options for the reminder postal request
Number of subjects: 752
Study 22687704 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 752
Study 22687704 — intervention group
Group type: COMPARATOR
Intervention: Group B
Number of subjects: 752
Study 20232761 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low intensity training programme (8 weeks, 35‐9% HR max reserve, 45-60 minutes)
Number of subjects: 217
Study 20232761 — intervention group
Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 217
Study 20232761 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low intensity training programme
Number of subjects: 217
Study 18361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis intervention for tuberculosis
Number of subjects: 0
Study 18361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis intervention for leprosy
Number of subjects: 0
Study 18361309 — intervention group
Group type: COMPARATOR
Intervention: Control group for tuberculosis
Number of subjects: 0
Study 18361309 — intervention group
Group type: COMPARATOR
Intervention: Control group for leprosy
Number of subjects: 0
Study 15940774 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 4000 mg
Number of subjects: 1578
Study 15940774 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg
Number of subjects: 1578
Study 15940774 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 12.5 mg
Number of subjects: 1578
Study 15940774 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 1578
Study 15940774 — intervention group
Group type: COMPARATOR
Intervention: Rofecoxib 25 mg vs Celecoxib 200 mg
Number of subjects: 1578
Study 15940774 — intervention group
Group type: COMPARATOR
Intervention: Pooled analysis of VACT1/VACT2
Number of subjects: 1578
Study 15940774 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 1578
Study 12408199 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention strategy implementing school environmental change with adult leader and youth participation
Number of subjects: 16
Study 12408199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study 11563412 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg with sertraline 50 mg
Number of subjects: 28
Study 11563412 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem alone
Number of subjects: 28
Study 7735741 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-residue diet
Number of subjects: 281
Study 7735741 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 281
Study 1782951 — intervention group
Group type: EXPERIMENTAL
Intervention: alteplase 100 mg in 3 h
Number of subjects: 36
Study 1782951 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36